Cargando…
Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study
INTRODUCTION: Achieving the Joint United Nations Programme on HIV and AIDS 90-90-90 targets requires models of HIV care that expand antiretroviral therapy (ART) coverage without overburdening health systems. Point-of-care (POC) viral load (VL) testing has the potential to efficiently monitor ART tre...
Autores principales: | Dorward, Jienchi, Garrett, Nigel, Quame-Amaglo, Justice, Samsunder, Natasha, Ngobese, Hope, Ngomane, Noluthando, Moodley, Pravikrishnen, Mlisana, Koleka, Schaafsma, Torin, Donnell, Deborah, Barnabas, Ruanne, Naidoo, Kogieleum, Abdool Karim, Salim, Celum, Connie, Drain, Paul K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623564/ https://www.ncbi.nlm.nih.gov/pubmed/28963304 http://dx.doi.org/10.1136/bmjopen-2017-017507 |
Ejemplares similares
-
Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes
por: Bardon, Ashley R, et al.
Publicado: (2021) -
Protocol for a randomised feasibility study of Point-Of-care HIV viral load testing to Enhance Re-suppression in South Africa: the POwER study
por: Dorward, Jienchi, et al.
Publicado: (2021) -
Understanding how community antiretroviral delivery influences engagement in HIV care: a qualitative assessment of the Centralised Chronic Medication Dispensing and Distribution programme in South Africa
por: Dorward, Jienchi, et al.
Publicado: (2020) -
Comparative cost analysis of point-of-care versus laboratory-based testing to initiate and monitor HIV treatment in South Africa
por: Simeon, Kate, et al.
Publicado: (2019) -
CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women
por: Gengiah, Tanuja Narayansamy, et al.
Publicado: (2022)